Picot Final
Picot Final
Picot Final
TO THE BASICS:
PREVENTION OF CLABSI
Halle Venechuk, Karissa Rossow, Mckenna Miling
University of Mary
27 April 2023
Introduction
https://www.bactiguard.com/wp-content/uploads/2020/03/bip-central-venous-catheter-low.png https://www.myamericannurse.com/wp-content/uploads/2019/06/Screen-Shot-2019-06-19-at-3.52.09-AM-e1560930813940.png
https://www.vascularwellness.com/wp-content/uploads/2021/09/Small-Bore-Internal-Jugular-Central-Venous-Catheter-Lines-2.jpg
CURRENT CDC Current Recommendations
Organisms (CLABSI)
History •
•
Gram-positive organisms are the most common (60%)
and
Gram Negatives (17.7%)
• Candida species (11.8%)
• Others (10.5%)
CLABSI prevention
Clinical Significance
https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcSpmAPHOHotb4TPeCH173kDM-
PSS1G2kfJODOjPQ_ojQ986G6hgILrEbVIQQeETfTabFjE&usqp=CAU
Prolonged Hospital Stay https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcQ96tV8b02h15nmiyti8zh53cT0LzuktMWUGqlbyFVw0nUJ4-
ZSadf4Z0jh1qni5yiA_Rg&usqp=CAU
with Chlorhexidine -
-
Octenidine: 1.47 CLABSI/1000 CL days
Soap and Water: 1.17 CLABSI/ 1000 CL days
or Octenidine – Conclusions
A Post-hoc Analysis of a - 0.08% octenidine and soap and water groups
were NOT statistically significant for reducing
CLABSI
• Inconclusive
2% CHG bathing (Reis et al., 2022) and 4% CHG bathing (Pallotto et al., 2019)
were not significant in decreasing CLABSI.
https://www.google.com/url?sa=i&url=https%3A%2F%2Fpdihc.com%2Fproducts%2Finterventional-care%2Fprevantics-device-
swab-strip
https://www.google.com/url?sa=i&url=https%3A%2F%2Fpdihc.com%2Fproducts%2Finterventional-care%2Fprevantics- %2F&psig=AOvVaw30nNBrPv_BQ1OGdrHFTEXV&ust=1682014649089000&source=images&cd=vfe&ved=0CBAQjRxqFwo
device-swab-strip TCJjktf_Gtv4CFQAAAAAdAAAAABAi
%2F&psig=AOvVaw30nNBrPv_BQ1OGdrHFTEXV&ust=1682014649089000&source=images&cd=vfe&ved=0CBAQjRxqF
woTCJjktf_Gtv4CFQAAAAAdAAAAABBB
■ Detailed
■ Clear Plan
■ The employees have a voice in the change
■ Sense of urgency in the method
https://getlucidity.com/strategy-resources/guide-to-kotters-8-step-change-model/
https://arpsp.cdc.gov/profile/nhsn/clabsi#:~:text=HAI%20Profile&text=The%20Standardized%20Infection%20Ratio%20for,acute%20care%20hospitals%20in%202021.
Create a Coalition
■ Unit Nurses that work directly with central lines
■ Managers on units that have reoccurring central lines on units
■ Physicians who insert lines, and continue care on the patients
■ Ask each group/people…
– Common practice
– Thoughts about the change proposal per unit
– How they like to get their information
– How they like to be educated on the information
the
Action Show appreciation to the staff
** REMINDER **
More research is needed
X X
https://www.walmart.com/ip/Hibiclens-Antibacterial-Hand-Soap-Antiseptic-Skin-Cleanser-8-oz-Wound-4-CHG-For-Surgery-
Antimicrobial-Home-Hospital/2148077428
https://www.roswellpark.org/cancertalk/202203/preparing-surgery-chg-cloths
https://www.google.com/url?sa=i&url=https%3A%2F%2Fpdihc.com%2Fproducts%2Finterventional-care%2Fprevantics-device-swab-strip%2F&psig=AOvVaw30nNBrPv_BQ1OGdrHFTEXV&ust=1682014649089000&source=images&cd=vfe&ved=0CBAQjRxqFwoTCJjktf_Gtv4CFQAAAAAdAAAAABBB
References
Bell, T., & O'Grady, N. P. (2017). Prevention of central line-associated bloodstream infections. Infectious disease clinics of North America, 31(3),
551–559. https://doi.org/10.1016/j.idc.2017.05.007
Centers for Disease Control and Prevention (CDC). (2011). Central line-associated bloodstream infections: Resources for patients and healthcare
providers. https://www.cdc.gov/hai/bsi/clabsi-resources.html
Centers for Disease Control and Prevention (CDC). (2021). 2020 national and state healthcare-associated infections (HAI) progress report.
https://arpsp.cdc.gov/profile/national-progress/united-states
Cooney, R. M., (2018). “The effectiveness of 3.15% chlorhexidine gluconate/70% alcohol disinfection to prevent central line-associated blood
Cooney, R. M., Manickam, N., Becherer, P., Harmon, L. S., Gregg, L., Farkas, Z., Shea, L. M., Parekh, P., Murphy, J., & Shade, W. (2020). The
use of 3.15% chlorhexidine gluconate/70% alcohol hub disinfection to prevent central line-associated bloodstream infections in dialysis
patients. British journal of nursing (Mark Allen Publishing), 29(2), S24–S26. https://doi.org/10.12968/bjon.2020.29.2.S24
References
Denkel, L. A., Schwab, F., Clausmeyer, J., Behnke, M., Golembus, J., Wolke, S., Gastmeier, P., & Geffers, C. (2022, November 1). Central-line associated
bloodstream infections in intensive care units before and after implementation of daily antiseptic bathing with chlorhexidine or octanedione-A post-hoc
Habboush, Y., Yarrarapu, S. N. S., & Guzman, N. (2022). Infection control. StatPearls [Internet]. https://www.ncbi.nlm.nih.gov/books/NBK519017/
O’Grady, N. P., Alexander, M., Dellinger, E. P., Gerberding, J. L., Heard, S. O., Maki, D. G., Masur, H., McCormick, R. D., Mermel, L. A., Pearson, M. L., Raad, I.
I., Randolph, A., & Weinstein, R. A. (2002) Guidelines for the prevention of intravascular catheter-related infections. Recommendations and Reports, 51(10),
1-26. https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5110a1.htm.
Lavelle, J., & Costarino, A. (2016). Central venous cannulation. Obgyn Key. https://obgynkey.com/central-venous-cannulation/
McPheeters, R., & Catoera, I. (2023). Central venous access via external jugular vein. Medscape. https://emedicine.medscape.com/article/2116323-
overview#:~:text=Central%20venous%20catheterization%2C%20or%20central,heart%20through%20his%20cephalic%20vein.
Pallotto, C., Fiorio, M., De Angelis, V., Ripoli, A., Franciosini, E., Quondam Girolamo, L., Volpi, F., Iorio, P., Francisci, D., Tascini, C., & Baldelli, F. (2019). Daily
bathing with 4% chlorhexidine gluconate in intensive care settings: A randomized controlled trial. Clinical microbiology and infection: The official
publication of the European Society of Clinical Microbiology and Infectious Diseases, 25(6), 705–710. https://doi.org/10.1016/j.cmi.2018.09.012
References
Reis, M. A. O., de Almeida, M. C. S., Escudero, D., & Medeiros, E. A. (2022). Chlorhexidine gluconate bathing of adult patients in intensive care
units in São Paulo, Brazil: Impact on the incidence of healthcare-associated infection. The Brazilian journal of infectious diseases: An
official publication of the Brazilian Society of Infectious Diseases, 26(1), 101666. https://doi.org/10.1016/j.bjid.2021.101666
Scheier, T., Saleschus, D., Dunic, M., Fröhlich, M. R., Schüpbach, R., Falk, C., Sax, H., Kuster, S. P., & Schreiber, P. W. (2021). Implementation
of daily chlorhexidine bathing in intensive care units for reduction of central line-associated bloodstream infections. The Journal of
Schmidt, N. A. & Brown, J. M. (2022). Evidence-based practice for nurses: Appraisal and application of research (5th ed.). Burlington, MA:
https://www.jointcommission.org/resources/patient-safety-topics/infection-prevention-and-control/central-line-associated-bloodstream-infe
ctions-toolkit-and-monograph/variability-of-surveillance-practices-for-central-lineassociated-bloodstream-infections-and-its-impl/#:~:text=
Central%20line%2Dassociated%20bloodstream%20infections%20(CLABSIs)%20are%20health%20care,to%20%242.3%20billion%20a%
20year
Toor, H., Farr, S., Savla, P., Kashyap, S., Wang, S., & Miulli, D. E. (2022). Prevalence of central line-associated bloodstream infections
(CLABSI) in intensive care and medical-surgical units. Cureus, 14(3), e22809. https://doi.org/10.7759/cureus.22809
Zerr, D. M., Milstone, A. M., Dvorak, C. C., Adler, A. L., Chen, L., Villaluna, D., Dang, H., Qin, X., Addetia, A., Yu, L. C., Conway Keller, M.,
Esbenshade, A. J., August, K. J., Fisher, B. T., & Sung, L. (2021). Chlorhexidine gluconate bathing in children with cancer or those
undergoing hematopoietic stem cell transplantation: A double-blinded randomized controlled trial from the Children's Oncology